About Dr. Zeng Mengsu
Dr. Zeng Mengsu (曾蒙苏) is one of China's most distinguished radiologists and the Director of the Department of Radiology at Zhongshan Hospital, affiliated with Fudan University. He holds the title of Chief Physician and Professor and is internationally recognized as a leading authority on abdominal MRI, liver imaging, and oncologic radiology.
Dr. Zeng is one of Asia's most respected abdominal radiologists, with a global reputation built through decades of landmark research on liver MRI techniques, hepatocellular carcinoma imaging, and gadoxetate disodium-enhanced MRI. His work has been published in the world's top radiology journals and has directly influenced international imaging guidelines for liver cancer diagnosis. He is one of the few Chinese radiologists to serve on the editorial board of Radiology — the most prestigious journal in the field.
For international patients requiring expert radiological interpretation of complex liver, pancreatic, or oncologic imaging — or those seeking a second opinion on imaging studies performed overseas — Dr. Zeng is one of the most sought-after radiologists in Asia.
Professional Positions and Affiliations
- Director, Department of Radiology, Zhongshan Hospital, Fudan University
- President, Asian Society of Abdominal Radiology (ASAR)
- Vice President, Chinese Society of Radiology
- Editorial Board Member: Radiology, European Radiology, Journal of Magnetic Resonance Imaging (JMRI), Abdominal Radiology
- Fellow, Radiological Society of North America (RSNA)
- Fellow, European Society of Radiology (ESR)
- Fellow, Society of Abdominal Radiology (SAR)
Specialties and Clinical Expertise
- Liver MRI — gadoxetate disodium (Primovist/Eovist) enhanced MRI for HCC diagnosis and characterization using LI-RADS; diffusion-weighted imaging (DWI); treatment response assessment after TACE, ablation, and systemic therapy using mRECIST; detection of small HCC lesions in cirrhotic livers
- Hepatocellular Carcinoma (HCC) Imaging — staging, resectability assessment, and treatment planning; vascular invasion evaluation; post-treatment surveillance
- Pancreatic Imaging — pancreatic cancer staging and vascular involvement assessment; IPMN characterization and malignancy risk stratification; neuroendocrine tumor imaging; autoimmune pancreatitis diagnosis
- Biliary Imaging — MRCP for bile duct stones, strictures, and cholangiocarcinoma; hilar cholangiocarcinoma staging
- Oncologic Staging and Response Assessment — CT and MRI staging for gastrointestinal, hepatobiliary, and genitourinary cancers; RECIST and mRECIST; PET-CT interpretation coordination
- Abdominal and Pelvic MRI — rectal cancer MRI staging; prostate MRI (PI-RADS); adrenal lesion characterization; renal mass evaluation
- AI-Assisted Radiology — development and validation of deep learning algorithms for liver lesion detection and HCC diagnosis; pioneer of AI integration in abdominal radiology
- Imaging Second Opinions — expert re-interpretation of complex liver, pancreatic, and oncologic imaging studies from overseas institutions
Academic and Research Contributions
Dr. Zeng Mengsu has published over 280 peer-reviewed papers in leading international radiology journals, making him one of the most prolific and highly cited radiologists in Asia. His landmark research on gadoxetate disodium-enhanced MRI for HCC detection and characterization — demonstrating superior sensitivity compared to conventional extracellular contrast agents, particularly for small lesions — has been cited thousands of times and has directly influenced EASL, AASLD, and APASL guidelines for HCC imaging diagnosis.
He serves as President of the Asian Society of Abdominal Radiology (ASAR) — the premier abdominal radiology society in Asia — and is one of the few Chinese radiologists to serve on the editorial board of Radiology. He has led multicenter studies on AI-assisted HCC detection and LI-RADS implementation in Chinese clinical practice, and is a regular invited speaker at RSNA, ECR, and ASAR annual meetings.
Hospital: Zhongshan Hospital Radiology Department
Under Dr. Zeng's leadership, Zhongshan Hospital's Radiology Department operates:
- Multiple state-of-the-art 3T MRI Scanners with advanced liver, cardiac, and oncologic imaging protocols
- A Dual-Energy CT Program for advanced oncologic staging and liver lesion characterization
- An AI-Assisted Diagnosis Platform for liver lesion detection and HCC characterization
- A Dedicated Oncologic Imaging Team participating in all major multidisciplinary tumor boards
- A Teleradiology and Second Opinion Service for complex imaging cases
Why International Patients Choose Dr. Zeng Mengsu
- President of the Asian Society of Abdominal Radiology — the highest position in Asian abdominal radiology
- Radiology editorial board member — one of the most prestigious positions in global radiology
- Gadoxetate-enhanced liver MRI pioneer — his research directly shaped international HCC imaging guidelines
- RSNA, ESR, and SAR Fellow — internationally credentialed across all major radiology societies
- AI radiology leader — developing validated deep learning tools for liver cancer detection
- Second opinion expertise — expert re-reads of complex overseas liver and oncologic imaging
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Zhongshan Hospital, 180 Fenglin Road, Xuhui District, Shanghai
- Second Opinion Service: Overseas imaging (CT, MRI, PET-CT) can be submitted for expert re-read through CMCS before travel
- Imaging at Zhongshan: CMCS can arrange priority scheduling for MRI and CT studies
- Languages: Mandarin Chinese; English interpretation provided by CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides support for international patients requiring expert radiological interpretation at Zhongshan Hospital. Our services include coordination of imaging second opinion requests, priority scheduling for MRI and CT studies, translation of imaging reports, and integration of radiology findings into multidisciplinary consultation appointments.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 commentaire